⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers
globenewswire.com
AZN
MRK
NVS
PFE
BMY
SNY
AMGN
JNJ
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight
prnewswire.com
BIIB
RPRX
UCB
VTRS
NVS
KZR
GSK
AZN
ABBV
BMY
JNJ
Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty
prnewswire.com
HRZN
NVS
MRK
Drug-Delivery Technology Market Report 2026
globenewswire.com
MRK
ABBV
SNY
AZN
NVS
GSK
TEVA
REGN
VRTX
ALKS
HALO
Chronic Kidney Disease Market to Reach $131.4 Billion by 2030, Driven by Rising Prevalence and Healthcare Infrastructure Investment
globenewswire.com
FMS
BAX
DVA
AMGN
PFE
NVS
Blow-Fill-Seal Technology Market Report 2026
globenewswire.com
GSK
PFE
MRK
JNJ
TEVA
AZN
CAT
NVS
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
globenewswire.com
NVS
LLY
Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform
globenewswire.com
LLY
NVS
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
globenewswire.com
NVS
Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights
globenewswire.com
BMY
MRK
AZN
PFE
REGN
GILD
AMGN
BE
LLY
IOVA
NVS